Cerebral metabolism in HIV infected patients with non-cognitive disorder using single voxel magnetic resonance spectroscopy

Fengli, 2012, An initial screening for HIV-1 associated neurocognitive disorders in HIV-1 infected patients in China, J Cap Med Univ, 33, 610 Walsh, 2003, HIV-1/AIDS neuropathology in a Canadian teaching centre, Can J Neurol Sci, 31, 235, 10.1017/S0317167100053889 Sacktor, 2005, The international HIV dementia Scale: a new rapid screening test for HIV dementia, AIDS, 19, 1367 Valcour, 2011, Pathogenesis of HIV in the central nervous system, Curr HIV/AIDS Reports, 8, 54, 10.1007/s11904-010-0070-4 Paul, 2007, Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity, J Neuropsychiatry Clin Neurosci, 19, 283, 10.1176/jnp.2007.19.3.283 Peluso, 2013, Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection, J Infect Dis, 207, 1703, 10.1093/infdis/jit088 Winston, 2012, Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy, Neuroradiology, 54, 1331, 10.1007/s00234-012-1061-5 Masters, 2014, Role of neuroimaging in HIV-associated neurocognitive disorders, Semin Neurol, 34, 89, 10.1055/s-0034-1372346 Morgan, 2010, Brain metabolism and cognitive impairment in HIV infection a 3T magnetic resonance spectroscopy study, Magn Reson Imaging, 28, 1251, 10.1016/j.mri.2010.06.007 Lentz, 2009, Changes in MRS neuronal markers and T Cell phentypes observed during early HIV infection, Neurology, 72, 1465, 10.1212/WNL.0b013e3181a2e90a Suwanwela, 2000, Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients, Magn Reson Imaging, 18, 859, 10.1016/S0730-725X(00)00173-9 Lentz, 2011, Alterations in brain metabolism during the first year of HIV infection, J Neurovirol, 17, 220, 10.1007/s13365-011-0030-9 J1, 2014, Predictors of CNS injury as measured by proton magnetic resonance spectroscopy in the setting of chronic HIVinfection and CART, J Neurovirol, 20, 294, 10.1007/s13365-014-0246-6